Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BEVA launches antimicrobial monitoring campaign
"It is important that we demonstrate, as a sector, that our usage of antimicrobials is responsible and proportionate, to ensure continued access." - Bruce Bladon
MonitorME will collect data from equine practices across the UK.

The British Equine Veterinary Association (BEVA) has launched a new campaign, as it aims to better understand how antibiotics are used in the equine sector.

The MonitorME project was launched this month to gather antimicrobial usage data from equine practices across the UK.

BEVA is urging practices to share usage data from their practice management systems to the BEVA office. This will be collated to create a nationwide data set of antimicrobial usage in the equine sector.

The information will ideally include the total mg of each antimicrobial used. It should also include the total number of horses treated by the practice in the past year, regardless of whether they were treated with antibiotics, and their average weight.

The data will be analysed and collated into an annual report, which will then be published on the BEVA MonitorME webpage.

The organisation’s 2023 report on antimicrobial usage is already available, but will be continually updated as practices submit their 2023 data. BEVA has already started collating data from 2024.

The new campaign will feature as a key theme at this year’s BEVA Congress, as the organisation aims to demonstrate the sector’s responsible approach to antimicrobial usage.

BEVA president Bruce Bladon said: “Growing resistance to antibiotics is a very serious public health crisis, which is why I have chosen it as the overriding theme for my presidential year and for the forthcoming BEVA Congress,

“The World Health Organisation has the usage of veterinary antimicrobials firmly in their sights and the possibility of legislation being implemented to limit our access to these vital drugs is becoming ever more likely.
 
“It is important that we demonstrate, as a sector, that our usage of antimicrobials is responsible and proportionate, to ensure continued access. Taking part in a project like this is, without a doubt, the right thing to do.”

There is more information on the BEVA MonitorME webpage, or practices can submit their data to antibiotics@beva.org.uk for collation into the 2024 data set.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.